Arinze Favour Anyiam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Arinze Favour Anyiam has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Onyinye Cecilia Arinze-Anyiam
Igbinedion University
7 shared publications - Ejeatuluchukwu Obi
Nnamdi Azikiwe University
5 shared publications - Emmanuel Anyachukwu Irondi
Kwara State University, Malete
3 shared publications - Danladi Chiroma Husaini
University of Belize
2 shared publications - Emmanuel Ifeanyi Obeagu
Division of Haematology, Department of Biomedical and Laboratory Science, Africa University
2 shared publications - Musa Abidemi Muhibi
Department of Medical Laboratory Science Edo State University Uzairue Nigeria
2 shared publications
Latest Publications
- 15 September 2026
- Published by Science Alert in Journal of Medical Sciences
- Vol. 26 (1) , 7-15
Haematological and Renal Function Markers Among Cigarette Smokers and Alcohol Consumers: A Pooled Analysis of Two Cross-Sectional Studies in Ilorin, Nigeria
- 15 September 2026
- Published by Science Alert in Journal of Medical Sciences
- Vol. 26 (1) , 7-15
Haematological and Renal Function Markers Among Cigarette Smokers and Alcohol Consumers: A Pooled Analysis of Two Cross-Sectional Studies in Ilorin, Nigeria
- 29 May 2025
- Published by Springer Nature
- p. 975-1013
Edible Mushroom and Respiratory Diseases
- Open Access
- 31 December 2024
- Published by Maad Rayan Publishing Company in Avicenna Journal of Medical Biochemistry
- Vol. 12 (2) , 114-122
Anti-inflammatory Effects of Phyllanthus amarus Extracts Against Benzene-Induced Leukemia in Rats
Background: The present study examined the protective effects of extracts from Phyllanthus amarus on benzene-induced leukemia in Wistar rats. Benzene is a carcinogen linked to increased leukemia risk. Objectives: The study aimed to assess the impact of P. amarus extracts, prepared via different drying methods, on immunological, biochemical, and histopathological parameters. Methods: Aqueous, methanolic, and ethanolic extracts were prepared from P. amarus using room drying, oven drying, and sun drying. The rats were treated with benzene and the extracts. For the immunological parameters, C-reactive protein (CRP), interleukin-8 (IL-8), transforming growth factor-beta (TGF-β), tumor necrosis factor-alpha (TNF-α), and IL-10 were measured using the enzyme-linked immunosorbent assay. For biochemical parameters, microalbumin, urea, creatinine, alanine aminotransferase (ALT), alkaline phosphatase (ALP), and aspartate aminotransferase (AST) were assessed using spectrophotometry. At the same time, for histopathological examination, liver and bone marrow tissues were stained using hematoxylin and eosin and analyzed for morphological changes. Results: Research findings showed no significant difference in CRP among the groups (P=0.197), indicating no significant inflammation or tissue damage. TGF-β levels were significantly lower in treatment groups compared to the positive control group (P=0.015), suggesting anti-inflammatory or immunosuppressive effects. No significant differences were found in IL-8, TNF-α, and IL-10 levels. The aqueous extract prepared by room drying significantly decreased microalbumin levels (P=0.016), representing potential protective effects on kidney function. The methanolic extract prepared by sun drying significantly reduced creatinine (P=0.032) and ALT (P=0.048) levels, implying beneficial effects on liver function. Histopathological examinations revealed that the extracts modulated bone marrow and liver morphologies, reducing inflammation while improving cellularity and morphology. Conclusion: P. amarus extracts demonstrated potential anti-inflammatory effects in benzene-induced leukemia by significantly reducing TGF-β levels without inducing inflammation, as evidenced by stable CRP, IL-8, and TNF-α levels. These findings suggest that the extracts may help mitigate inflammation associated with benzene exposure, highlighting their potential as adjunctive therapies in leukemia treatment. More studies are needed to understand these protective processes completely and investigate their clinical uses.
- 31 December 2024
- Published by Maad Rayan Publishing Company in Avicenna Journal of Medical Biochemistry
- Vol. 12 (2) , 114-122
Open AccessAnti-inflammatory Effects of Phyllanthus amarus Extracts Against Benzene-Induced Leukemia in Rats
Background: The present study examined the protective effects of extracts from Phyllanthus amarus on benzene-induced leukemia in Wistar rats. Benzene is a carcinogen linked to increased leukemia risk. Objectives: The study aimed to assess the impact of P. amarus extracts, prepared via different drying methods, on immunological, biochemical, and histopathological parameters. Methods: Aqueous, methanolic, and ethanolic extracts were prepared from P. amarus using room drying, oven drying, and sun drying. The rats were treated with benzene and the extracts. For the immunological parameters, C-reactive protein (CRP), interleukin-8 (IL-8), transforming growth factor-beta (TGF-β), tumor necrosis factor-alpha (TNF-α), and IL-10 were measured using the enzyme-linked immunosorbent assay. For biochemical parameters, microalbumin, urea, creatinine, alanine aminotransferase (ALT), alkaline phosphatase (ALP), and aspartate aminotransferase (AST) were assessed using spectrophotometry. At the same time, for histopathological examination, liver and bone marrow tissues were stained using hematoxylin and eosin and analyzed for morphological changes. Results: Research findings showed no significant difference in CRP among the groups (P=0.197), indicating no significant inflammation or tissue damage. TGF-β levels were significantly lower in treatment groups compared to the positive control group (P=0.015), suggesting anti-inflammatory or immunosuppressive effects. No significant differences were found in IL-8, TNF-α, and IL-10 levels. The aqueous extract prepared by room drying significantly decreased microalbumin levels (P=0.016), representing potential protective effects on kidney function. The methanolic extract prepared by sun drying significantly reduced creatinine (P=0.032) and ALT (P=0.048) levels, implying beneficial effects on liver function. Histopathological examinations revealed that the extracts modulated bone marrow and liver morphologies, reducing inflammation while improving cellularity and morphology. Conclusion: P. amarus extracts demonstrated potential anti-inflammatory effects in benzene-induced leukemia by significantly reducing TGF-β levels without inducing inflammation, as evidenced by stable CRP, IL-8, and TNF-α levels. These findings suggest that the extracts may help mitigate inflammation associated with benzene exposure, highlighting their potential as adjunctive therapies in leukemia treatment. More studies are needed to understand these protective processes completely and investigate their clinical uses.
- Open Access
- 24 October 2024
- Published by Sciencedomain International
- Vol. 7 (4) , 180-192
Assessment of Coagulation Profiles and Investigation of Leukaemia Incidence in Sickle Cell Patients at Lagos University Teaching Hospital
Aims: The purpose of this research was to assess and compare the coagulation and haematological profiles of sickle cell disease (SCD) patients to those without the condition, as well as to ascertain the incidence of leukaemia in SC patients. It specifically examined if there were any observable variations between SCD patients with and without leg ulcers, as well as variances in coagulation parameters including prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen, and D-Dimer levels. Study Design: In order to ascertain the incidence of leukaemia and evaluate the coagulation and haematological profiles of sickle cell patients (steady state) with leg ulcers, as well as non-leg ulcer and non-sickle cell persons as the control group, this study used a case control design. Place and Duration of Study: The study was conducted at the Sickle Cell Foundation Nigeria, Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria, from May to September 2024. Methodology: A questionnaire was developed and administered to both patients with sickle cell disease (SCD) at their steady state and individuals in the control group (non-SCD). Ninety-two (92) participants were recruited for this study, of which 80 met the inclusion criteria. Fifty (50) subjects were of the SCD case group, while 30 were of the non-SCD control group. The 80 consenting participants comprised 44 males and 36 females. The average age for SCD cases was 19.58 ± 9.8 years, while controls averaged 27.4 ± 12.3 years. Investigations were carried out on all the samples for Full Blood Count, coagulation profile, haemoglobin electrophoresis, ABO blood group, and peripheral blood film examination. Ethical approval was obtained from the College of Medicine, University of Lagos, and the Sickle Cell Foundation, Nigeria. Data were analyzed using t-tests to compare haematological and coagulation parameters between groups. All analyses were performed using R and Python to ensure accurate data analysis, which is crucial in clinical research. Results: While significant differences were found in haematological parameters between SCD patients and controls—specifically lower red blood cell counts, haematocrit, and haemoglobin levels, alongside elevated white blood cell and platelet counts (P < 0.001)—no new cases of leukemia were detected. Coagulation profiles, including PT and APTT, were prolonged in SCD patients (P < 0.001), though fibrinogen and D-Dimer levels showed no statistically significant differences between SCD and control groups (P = 0.563 and P = 0.223, respectively). Conclusion: The absence of leukaemia in our sample highlights the potential rarity of leukaemia in this SCD population. The coagulation profile anomalies highlight the therapeutic significance of monitoring thrombotic risks in the management of sickle cell disease (SCD), even if no significant connection with leukaemia was established. Our results shed light on the haemorrhagic problems associated with sickle cell disease (SCD), even when leukaemia is not present. They also imply that vigilant monitoring of coagulation parameters is still very essential to shield SCD patients from vascular complications.
- 24 October 2024
- Published by Sciencedomain International
- Vol. 7 (4) , 180-192
Open AccessAssessment of Coagulation Profiles and Investigation of Leukaemia Incidence in Sickle Cell Patients at Lagos University Teaching Hospital
Aims: The purpose of this research was to assess and compare the coagulation and haematological profiles of sickle cell disease (SCD) patients to those without the condition, as well as to ascertain the incidence of leukaemia in SC patients. It specifically examined if there were any observable variations between SCD patients with and without leg ulcers, as well as variances in coagulation parameters including prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen, and D-Dimer levels. Study Design: In order to ascertain the incidence of leukaemia and evaluate the coagulation and haematological profiles of sickle cell patients (steady state) with leg ulcers, as well as non-leg ulcer and non-sickle cell persons as the control group, this study used a case control design. Place and Duration of Study: The study was conducted at the Sickle Cell Foundation Nigeria, Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria, from May to September 2024. Methodology: A questionnaire was developed and administered to both patients with sickle cell disease (SCD) at their steady state and individuals in the control group (non-SCD). Ninety-two (92) participants were recruited for this study, of which 80 met the inclusion criteria. Fifty (50) subjects were of the SCD case group, while 30 were of the non-SCD control group. The 80 consenting participants comprised 44 males and 36 females. The average age for SCD cases was 19.58 ± 9.8 years, while controls averaged 27.4 ± 12.3 years. Investigations were carried out on all the samples for Full Blood Count, coagulation profile, haemoglobin electrophoresis, ABO blood group, and peripheral blood film examination. Ethical approval was obtained from the College of Medicine, University of Lagos, and the Sickle Cell Foundation, Nigeria. Data were analyzed using t-tests to compare haematological and coagulation parameters between groups. All analyses were performed using R and Python to ensure accurate data analysis, which is crucial in clinical research. Results: While significant differences were found in haematological parameters between SCD patients and controls—specifically lower red blood cell counts, haematocrit, and haemoglobin levels, alongside elevated white blood cell and platelet counts (P < 0.001)—no new cases of leukemia were detected. Coagulation profiles, including PT and APTT, were prolonged in SCD patients (P < 0.001), though fibrinogen and D-Dimer levels showed no statistically significant differences between SCD and control groups (P = 0.563 and P = 0.223, respectively). Conclusion: The absence of leukaemia in our sample highlights the potential rarity of leukaemia in this SCD population. The coagulation profile anomalies highlight the therapeutic significance of monitoring thrombotic risks in the management of sickle cell disease (SCD), even if no significant connection with leukaemia was established. Our results shed light on the haemorrhagic problems associated with sickle cell disease (SCD), even when leukaemia is not present. They also imply that vigilant monitoring of coagulation parameters is still very essential to shield SCD patients from vascular complications.
- Open Access
Phytochemical Composition, In Silico Molecular Docking Analysis and Antibacterial Activity of Lawsonia inermis Linn Leaves Extracts against Extended Spectrum Beta-Lactamases-Producing Strains of Klebsiella pneumoniae
Klebsiella pneumoniae is an opportunistic Gram-negative bacterium in the Enterobacteriaceae family associated with a wide range of diseases, such as pneumonia, bloodstream infections, meningitis and urinary tract infections. Infections caused by drug-resistant strains of Klebsiella pneumoniae pose a significant threat to the effectiveness of conventional antibiotics. Hence, this has led to the need to explore alternative antimicrobial therapies, especially natural products derived from plant sources. This study assessed the phytochemical composition and antibacterial properties and performed a molecular docking analysis of Henna leaves (Lawsonia inermis L.) extracts on strains of Klebsiella pneumoniae. Crude ethanol and methanol extracts of L. inermis L. were prepared at different concentrations (25, 50, 75 and 100 mg/mL) and tested on extended spectrum beta-lactamases (ESBLs)-producing strains of Klebsiella pneumoniae. Phytocompounds were identified using gas chromatography–mass spectrometry (GC-MS) and further subjected to virtual ligands screening with DataWarrior (v05.02.01) and a molecular docking analysis using AutoDock4.2 (v4.2.6). The active compounds of L. inermis L. were determined by the docking analysis, including phytochemical, physicochemical, pharmacokinetics and docking score. The GC-MS analysis identified 27 phytoconstituents, including ethyl acetate, sclareol, 2-[1,2-dihydroxyethyl]-9-[β-d-ribofuranosyl] hypoxanthine, α-bisabolol and 2-Isopropyl-5-methylcyclohexyl 3-(1-(4-chlorophenyl)-3-oxobutyl)-coumarin-4-yl carbonate. The 27 compounds were then screened for their physicochemical and pharmacokinetic properties. The results revealed that the methanol extracts at 100 mg/mL showed significantly higher (p < 0.05) zones of inhibition (13.7 ± 1.2 mm), while the ethanol extracts at 50 mg/mL were significantly lower (6.3 ± 0.6 mm) compared to all the other treatments. The docking analysis revealed that out of the 27 compounds identified, only twelve (12) compounds have a drug-likeness activity. The 12 compounds were further subjected to docking analysis to determine the binding energies with the CTX-M protein of Klebsiella pneumoniae. Only one compound [CID_440869; (2-[1,2-dihydroxyethyl]-9-[β-d-ribofuranosyl] hypoxanthine)] had the best binding energy of −9.76 kcal/mol; hence, it can be considered a potentially suitable treatment for infections caused by ESBLs-producing strains of Klebsiella pneumoniae. This study has demonstrated that L. inermis L. extracts have antibacterial effects. Further research could explore the potential antimicrobial applications of L. inermis L. extracts to many bacterial strains.
Open AccessPhytochemical Composition, In Silico Molecular Docking Analysis and Antibacterial Activity of Lawsonia inermis Linn Leaves Extracts against Extended Spectrum Beta-Lactamases-Producing Strains of Klebsiella pneumoniae
Klebsiella pneumoniae is an opportunistic Gram-negative bacterium in the Enterobacteriaceae family associated with a wide range of diseases, such as pneumonia, bloodstream infections, meningitis and urinary tract infections. Infections caused by drug-resistant strains of Klebsiella pneumoniae pose a significant threat to the effectiveness of conventional antibiotics. Hence, this has led to the need to explore alternative antimicrobial therapies, especially natural products derived from plant sources. This study assessed the phytochemical composition and antibacterial properties and performed a molecular docking analysis of Henna leaves (Lawsonia inermis L.) extracts on strains of Klebsiella pneumoniae. Crude ethanol and methanol extracts of L. inermis L. were prepared at different concentrations (25, 50, 75 and 100 mg/mL) and tested on extended spectrum beta-lactamases (ESBLs)-producing strains of Klebsiella pneumoniae. Phytocompounds were identified using gas chromatography–mass spectrometry (GC-MS) and further subjected to virtual ligands screening with DataWarrior (v05.02.01) and a molecular docking analysis using AutoDock4.2 (v4.2.6). The active compounds of L. inermis L. were determined by the docking analysis, including phytochemical, physicochemical, pharmacokinetics and docking score. The GC-MS analysis identified 27 phytoconstituents, including ethyl acetate, sclareol, 2-[1,2-dihydroxyethyl]-9-[β-d-ribofuranosyl] hypoxanthine, α-bisabolol and 2-Isopropyl-5-methylcyclohexyl 3-(1-(4-chlorophenyl)-3-oxobutyl)-coumarin-4-yl carbonate. The 27 compounds were then screened for their physicochemical and pharmacokinetic properties. The results revealed that the methanol extracts at 100 mg/mL showed significantly higher (p < 0.05) zones of inhibition (13.7 ± 1.2 mm), while the ethanol extracts at 50 mg/mL were significantly lower (6.3 ± 0.6 mm) compared to all the other treatments. The docking analysis revealed that out of the 27 compounds identified, only twelve (12) compounds have a drug-likeness activity. The 12 compounds were further subjected to docking analysis to determine the binding energies with the CTX-M protein of Klebsiella pneumoniae. Only one compound [CID_440869; (2-[1,2-dihydroxyethyl]-9-[β-d-ribofuranosyl] hypoxanthine)] had the best binding energy of −9.76 kcal/mol; hence, it can be considered a potentially suitable treatment for infections caused by ESBLs-producing strains of Klebsiella pneumoniae. This study has demonstrated that L. inermis L. extracts have antibacterial effects. Further research could explore the potential antimicrobial applications of L. inermis L. extracts to many bacterial strains.
- Open Access
- 22 August 2023
- Published by Maad Rayan Publishing Company in Avicenna Journal of Medical Biochemistry
- Vol. 11 (2) , 117-122
Effects of Methanolic Extract of Aloe vera on C-Reactive Protein and White Blood Cell Count of Wistar Rats With Inflammation
Background: It has been known for centuries that plants and plant-derived chemicals are useful in treating diseases, with Aloe vera being one of the biologically active plants. A significant role is played by the C-reactive protein (CRP) in many inflammatory conditions, while leukocytes play an integral role in the response of the immune system to infectious diseases. Objectives: This study explored the potential anti-inflammatory effects of Aloe vera methanolic extract on the total white blood cell (TWBC) count and CRP levels in Wistar rats received formalin. Methods: A total of 25 Wistar rats were divided into five groups (A to E), with group A serving as the control and the other groups receiving formalin to induce inflammation, followed by increasing doses of Aloe vera extract. The CRP level was measured using an enzyme-linked immunosorbent assay (ELISA) kit, and the TWBC count was determined using a Sysmex haematology autoanalyzer. Results: Research findings showed that 200 mg of Aloe vera methanolic extract effectively reduced the CRP level (0.056±0.0027) (P=0.04), while 600 mg of the extract significantly increased the TWBC count (13.920±4.757) (P=0.03). Conclusion: These findings suggest that Aloe vera extract may be an effective natural supplement for improving the immune system function and reducing inflammation in the body. However, further research is needed to fully understand the underlying mechanisms for these effects and to determine the optimal doses and potential side effects.
- 22 August 2023
- Published by Maad Rayan Publishing Company in Avicenna Journal of Medical Biochemistry
- Vol. 11 (2) , 117-122
Open AccessEffects of Methanolic Extract of Aloe vera on C-Reactive Protein and White Blood Cell Count of Wistar Rats With Inflammation
Background: It has been known for centuries that plants and plant-derived chemicals are useful in treating diseases, with Aloe vera being one of the biologically active plants. A significant role is played by the C-reactive protein (CRP) in many inflammatory conditions, while leukocytes play an integral role in the response of the immune system to infectious diseases. Objectives: This study explored the potential anti-inflammatory effects of Aloe vera methanolic extract on the total white blood cell (TWBC) count and CRP levels in Wistar rats received formalin. Methods: A total of 25 Wistar rats were divided into five groups (A to E), with group A serving as the control and the other groups receiving formalin to induce inflammation, followed by increasing doses of Aloe vera extract. The CRP level was measured using an enzyme-linked immunosorbent assay (ELISA) kit, and the TWBC count was determined using a Sysmex haematology autoanalyzer. Results: Research findings showed that 200 mg of Aloe vera methanolic extract effectively reduced the CRP level (0.056±0.0027) (P=0.04), while 600 mg of the extract significantly increased the TWBC count (13.920±4.757) (P=0.03). Conclusion: These findings suggest that Aloe vera extract may be an effective natural supplement for improving the immune system function and reducing inflammation in the body. However, further research is needed to fully understand the underlying mechanisms for these effects and to determine the optimal doses and potential side effects.